About Sequentia biotech
Sequentia biotech is a company based in Barcelona (Spain) founded in 2013. Sequentia biotech has raised $11.16 million across 9 funding rounds from investors including European Union, Seventure Partners and EIC Fund. Sequentia biotech offers products and services including Cloud Software, Custom Software, and Consulting Services. Sequentia biotech operates in a competitive market with competitors including Human Longevity, Omniome, Genomics, Depixus and Seven Bridges Genomics, among others.
- Headquarter Barcelona, Spain
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sequentia Biotech Sl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.16 M (USD)
in 9 rounds
-
Latest Funding Round
$11.16 M (USD), Series A
Sep 30, 2024
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sequentia biotech
Sequentia biotech offers a comprehensive portfolio of products and services, including Cloud Software, Custom Software, and Consulting Services.
User-friendly tools for daily omics data analysis tasks
Pipelines for processing large volumes of omics data
Expert guidance on transforming omics data into knowledge
People of Sequentia biotech
Unlock access to complete
Funding Insights of Sequentia biotech
Sequentia biotech has successfully raised a total of $11.16M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $11.16 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sequentia biotech
Sequentia biotech has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Seventure Partners and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Sequentia biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sequentia biotech
Investment portfolio details for Sequentia biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sequentia biotech
Detailed financials for Sequentia biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sequentia Biotech Comparisons
Peer comparison for Sequentia biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sequentia biotech
Sequentia biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, Omniome, Genomics, Depixus and Seven Bridges Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
Detailed competitors of Sequentia biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sequentia Biotech
Complete news archive for Sequentia biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sequentia biotech
Sequentia biotech was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Sequentia biotech is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Sequentia biotech is a funded company, having raised a total of $11.16M across 9 funding rounds to date.
Sequentia Biotech was founded in 2013 and is based in Barcelona, Spain. Operations in the bioinformatics sector are structured across four divisions: Sequentia Green, Sequentia Health, Sequentia Research, and Sequentia Training. Bioinformatics services, next-generation sequencing (NGS), and data analysis software are offered. Custom databases, including PRGdb for plant resistance genes and Variation DB, are also maintained to support specialized research needs.
Sequentia biotech's top competitors include Human Longevity, Novogene Corporation and Eagle Genomics.
Sequentia biotech offers Cloud Software, Custom Software, and Consulting Services.
Sequentia biotech has 3 investors. Key investors include European Union, Seventure Partners, and EIC Fund.